A newly found protein that helps the cell's protein-making center work

Uncovering novel players in nucleolar organization and function

NIH-funded research Ut Southwestern Medical Center · NIH-11376282

Researchers are looking at how a protein called ZNF692 that keeps the nucleolus organized might affect conditions like Alzheimer's disease and certain cancers.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center NIH-funded
Lab location1 site (Dallas, United States)
Project IDNIH-11376282 on NIH RePORTER

What this research studies

The team will focus on a nucleolar protein named ZNF692 that appears necessary for normal ribosome production and nucleolar structure. In lab-grown cells they will reduce or alter ZNF692 to see how nucleoli change and how protein synthesis is affected. They will map which parts of ZNF692 are required for its function and identify the other proteins and RNAs it binds. These experiments use cellular and biochemical methods to connect basic nucleolar biology to processes linked with neurodegeneration and cancer.

Who could benefit from this research

Good fit: People living with Alzheimer's disease or certain cancers who are interested in contributing tissue samples or joining future related studies would be the most relevant candidates.

Not a fit: Patients seeking immediate symptom relief or direct treatment are unlikely to benefit directly from this basic laboratory research.

Why it matters

Potential benefit: If successful, this work could reveal new molecular targets that might eventually lead to therapies to protect neurons or limit cancer cell growth by restoring nucleolar function.

How similar studies have performed: Previous research has linked nucleolar changes to cancer and neurodegeneration, but targeting or characterizing a novel factor like ZNF692 is largely new and untested.

Where this research is happening

Dallas, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseCancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.